| Code | 92753 | ||||||||||
| MA number | 29/0254/05-S | ||||||||||
| Product Form: | tbl oro 6x100 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Reckitt Benckiser (Czech Republic), spol. s r.o. , Czechia | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 17.08.2005 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_NUROFEN pre deti Active_11.2018.doc
|
| PIL: |
PIL_NUROFEN pre deti Active_02.2019.doc
|
| Safety feature | No |
| Data update: | 24.06.2020 |
